DIFFERENTIAL INHIBITION OF LIVER AND BRAIN MONOAMINE OXIDASE BY A SERIES OF ARYLALKYLHYDRAZINES

被引：17

作者：

MCGRATH, WR

HORITA, A

机构：

来源：

关键词：

D O I：

10.1016/0041-008X(62)90055-8

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：178 / &

共 13 条

[1] CENTRAL STIMULANTS - CHEMISTRY AND STRUCTURE ACTIVITY RELATIONSHIPS OF ARALKYL HYDRAZINES
BIEL, JH
DRUKKER, AE
MITCHELL, TF
SPRENGELER, EP
NUHFER, PA
CONWAY, AC
HORITA, A
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1959, 81 (11) : 2805 - 2813
[2] MECHANISM OF THE IRREVERSIBLE INHIBITION OF RAT-LIVER MONOAMINE OXIDASE BY IPRONIAZID (MARSILID)
DAVISON, AN
[J]. BIOCHEMICAL JOURNAL, 1957, 67 : 316 - 322
[3] DAVISON AN, 1958, B SOC CHIM BIOL, V40, P1737
[4] GOGERTY JH, 1960, J PHARMACOL EXP THER, V129, P357
[5] ROUTE OF ADMINISTRATION OF SOME HYDRAZINE COMPOUNDS AS A DETERMINANT OF BRAIN AND LIVER MONOAMINE OXIDASE INHIBITION
HORITA, A
[J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1961, 3 (04) : 474 - &
[6] HORITA A, 1960, P SOC EXP BIOL MED, V103, P753
[7] PHARMACOLOGY OF JB-516 (PIH)
HORITA, A
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1959, 80 (03) : 590 - 596
[8] HORITA A, 1958, J PHARMACOL EXP THER, V122, P176
[9] LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
[10] MAYER S, 1959, J PHARMACOL EXP THER, V127, P205